share_log

Citigroup Maintains Buy on Boston Scientific, Raises Price Target to $85

Benzinga ·  Apr 25 18:31

Citigroup analyst Joanne Wuensch maintains Boston Scientific (NYSE:BSX) with a Buy and raises the price target from $79 to $85.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment